134 related articles for article (PubMed ID: 8118876)
1. T cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Cell Immunol; 1994 Feb; 153(2):468-78. PubMed ID: 8118876
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous development of protective anti-T cell receptor autoimmunity targeted against a natural EAE-regulatory idiotope located within the 39-59 region of the TCR-V beta 8.2 chain.
Hashim GA; Offner H; Wang RY; Shukla K; Carvalho E; Morrison WJ; Vandenbark AA
J Immunol; 1992 Oct; 149(8):2803-9. PubMed ID: 1401912
[TBL] [Abstract][Full Text] [Related]
3. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
4. Antibodies specific for VB8 receptor peptide suppress experimental autoimmune encephalomyelitis.
Hashim GA; Vandenbark AA; Galang AB; Diamanduros T; Carvalho E; Srinivasan J; Jones R; Vainiene M; Morrison WJ; Offner H
J Immunol; 1990 Jun; 144(12):4621-7. PubMed ID: 1693637
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with T cell receptor peptides using a conventional immunization protocol does not induce effective protection against autoimmune encephalomyelitis.
Tanuma N; Abe S; Shin T; Kojima T; Ishihara Y; Arai Y; Toyoshima S; Matsumoto Y
Cell Immunol; 1996 Feb; 168(1):85-90. PubMed ID: 8599843
[TBL] [Abstract][Full Text] [Related]
6. Studies on T-cell receptors involved in experimental autoimmune encephalomyelitis using the complementary peptide recognition approach.
Xian CJ; Simmons RD; Willenborg DO; Vandenbark AA; Hashim GA; Carnegie PR
J Neurosci Res; 1995 Aug; 41(5):620-7. PubMed ID: 7563242
[TBL] [Abstract][Full Text] [Related]
7. Protection against experimental encephalomyelitis. Idiotypic autoregulation induced by a nonencephalitogenic T cell clone expressing a cross-reactive T cell receptor V gene.
Offner H; Vainiene M; Gold DP; Morrison WJ; Wang RY; Hashim GA; Vandenbark AA
J Immunol; 1991 Jun; 146(12):4165-72. PubMed ID: 1710243
[TBL] [Abstract][Full Text] [Related]
8. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to experimental autoimmune encephalomyelitis is independent of V beta usage.
Johnson BD; Nardella JP; McConnell TJ; Mannie MD
Cell Immunol; 1997 Jul; 179(1):55-65. PubMed ID: 9259772
[TBL] [Abstract][Full Text] [Related]
10. Specific modulation of T cells and murine experimental allergic encephalomyelitis by monoclonal anti-idiotypic antibodies.
Zhou SR; Whitaker JN
J Immunol; 1993 Feb; 150(4):1629-42. PubMed ID: 7679432
[TBL] [Abstract][Full Text] [Related]
11. Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.
Vandenbark AA; Hashim G; Offner H
Nature; 1989 Oct; 341(6242):541-4. PubMed ID: 2477708
[TBL] [Abstract][Full Text] [Related]
12. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
13. T-T cellular interaction between CD4-CD8- regulatory T cells and T cell clones presenting TCR peptide. Its implication for TCR vaccination against experimental autoimmune encephalomyelitis.
Kozovska MF; Yamamura T; Tabira T
J Immunol; 1996 Aug; 157(4):1781-90. PubMed ID: 8759768
[TBL] [Abstract][Full Text] [Related]
14. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
15. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
Aroeira LS
Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
[TBL] [Abstract][Full Text] [Related]
16. Increased severity of experimental autoimmune encephalomyelitis in rats tolerized as adults but not neonatally to a protective TCR V beta 8 CDR2 idiotope.
Offner H; Malotky MK; Pope L; Vainiene M; Celnik B; Miller SD; Vandenbark AA
J Immunol; 1995 Jan; 154(2):928-35. PubMed ID: 7529291
[TBL] [Abstract][Full Text] [Related]
17. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with BV8S2 protein amplifies TCR-specific regulation and protection against experimental autoimmune encephalomyelitis in TCR BV8S2 transgenic mice.
Offner H; Adlard K; Bebo BF; Schuster J; Burrows GG; Buenafe AC; Vandenbark AA
J Immunol; 1998 Sep; 161(5):2178-86. PubMed ID: 9725209
[TBL] [Abstract][Full Text] [Related]
19. Induction of peripheral tolerance with peptide-specific anergy in experimental autoimmune neuritis.
Gregorian SK; Clark L; Heber-Katz E; Amento EP; Rostami A
Cell Immunol; 1993 Sep; 150(2):298-310. PubMed ID: 7690307
[TBL] [Abstract][Full Text] [Related]
20. Presence of CpG DNA and the local cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis.
Lobell A; Weissert R; Eltayeb S; Svanholm C; Olsson T; Wigzell H
J Immunol; 1999 Nov; 163(9):4754-62. PubMed ID: 10528174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
